Post-earnings recap
Reported
Tue, May 5, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported a strong earnings per share, significantly beating expectations. However, the stock declined by 1.74% following the report, likely due to the lack of revenue data and forward guidance. Investors may be cautious as they await more information on future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | +84.85% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the earnings surprise but did not provide specific future guidance. They emphasized a commitment to long-term growth.
We are pleased with our EPS performance this quarter.
While we did not provide guidance, we remain focused on our long-term strategy.